Treating acute pancreatitis: What's new?

Vikesh Singh, Robert A. Moran, Elham Afghani, Enrique De-Madaria

Research output: Contribution to journalArticle

Abstract

The medical treatment of acute pancreatitis continues to focus on supportive care, including fluid therapy, nutrition, and antibiotics, all of which will be critically reviewed. Pharmacologic agents that were previously studied were found to be ineffective likely due to a combination of their targets and flaws in trial design. Potential future pharmacologic agents, particularly those that target intracellular calcium signaling, as well as considerations for trial design will be discussed. As the incidence of acute pancreatitis continues to increase, greater efforts will be needed to prevent hospitalization, readmission and excessive imaging in order to reduce overall healthcare costs. Primary prevention continues to focus on post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis and secondary prevention on cholecystectomy for biliary pancreatitis as well as alcohol and smoking abstinence.

Original languageEnglish (US)
Pages (from-to)901-911
Number of pages11
JournalExpert Review of Gastroenterology and Hepatology
Volume9
Issue number7
DOIs
StatePublished - Sep 1 2015

Fingerprint

Pancreatitis
Alcohol Abstinence
Calcium Signaling
Endoscopic Retrograde Cholangiopancreatography
Fluid Therapy
Cholecystectomy
Primary Prevention
Secondary Prevention
Health Care Costs
Hospitalization
Smoking
Anti-Bacterial Agents
Incidence
Therapeutics

Keywords

  • acute pancreatitis
  • clinical trials
  • drugs
  • medical therapy
  • primary prevention
  • resource utilization
  • secondary prevention

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Treating acute pancreatitis : What's new? / Singh, Vikesh; Moran, Robert A.; Afghani, Elham; De-Madaria, Enrique.

In: Expert Review of Gastroenterology and Hepatology, Vol. 9, No. 7, 01.09.2015, p. 901-911.

Research output: Contribution to journalArticle

Singh, Vikesh ; Moran, Robert A. ; Afghani, Elham ; De-Madaria, Enrique. / Treating acute pancreatitis : What's new?. In: Expert Review of Gastroenterology and Hepatology. 2015 ; Vol. 9, No. 7. pp. 901-911.
@article{d46d6563931c4886803baed5c687f8f0,
title = "Treating acute pancreatitis: What's new?",
abstract = "The medical treatment of acute pancreatitis continues to focus on supportive care, including fluid therapy, nutrition, and antibiotics, all of which will be critically reviewed. Pharmacologic agents that were previously studied were found to be ineffective likely due to a combination of their targets and flaws in trial design. Potential future pharmacologic agents, particularly those that target intracellular calcium signaling, as well as considerations for trial design will be discussed. As the incidence of acute pancreatitis continues to increase, greater efforts will be needed to prevent hospitalization, readmission and excessive imaging in order to reduce overall healthcare costs. Primary prevention continues to focus on post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis and secondary prevention on cholecystectomy for biliary pancreatitis as well as alcohol and smoking abstinence.",
keywords = "acute pancreatitis, clinical trials, drugs, medical therapy, primary prevention, resource utilization, secondary prevention",
author = "Vikesh Singh and Moran, {Robert A.} and Elham Afghani and Enrique De-Madaria",
year = "2015",
month = "9",
day = "1",
doi = "10.1586/17474124.2015.1048225",
language = "English (US)",
volume = "9",
pages = "901--911",
journal = "Expert Review of Gastroenterology and Hepatology",
issn = "1747-4124",
publisher = "Expert Reviews Ltd.",
number = "7",

}

TY - JOUR

T1 - Treating acute pancreatitis

T2 - What's new?

AU - Singh, Vikesh

AU - Moran, Robert A.

AU - Afghani, Elham

AU - De-Madaria, Enrique

PY - 2015/9/1

Y1 - 2015/9/1

N2 - The medical treatment of acute pancreatitis continues to focus on supportive care, including fluid therapy, nutrition, and antibiotics, all of which will be critically reviewed. Pharmacologic agents that were previously studied were found to be ineffective likely due to a combination of their targets and flaws in trial design. Potential future pharmacologic agents, particularly those that target intracellular calcium signaling, as well as considerations for trial design will be discussed. As the incidence of acute pancreatitis continues to increase, greater efforts will be needed to prevent hospitalization, readmission and excessive imaging in order to reduce overall healthcare costs. Primary prevention continues to focus on post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis and secondary prevention on cholecystectomy for biliary pancreatitis as well as alcohol and smoking abstinence.

AB - The medical treatment of acute pancreatitis continues to focus on supportive care, including fluid therapy, nutrition, and antibiotics, all of which will be critically reviewed. Pharmacologic agents that were previously studied were found to be ineffective likely due to a combination of their targets and flaws in trial design. Potential future pharmacologic agents, particularly those that target intracellular calcium signaling, as well as considerations for trial design will be discussed. As the incidence of acute pancreatitis continues to increase, greater efforts will be needed to prevent hospitalization, readmission and excessive imaging in order to reduce overall healthcare costs. Primary prevention continues to focus on post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis and secondary prevention on cholecystectomy for biliary pancreatitis as well as alcohol and smoking abstinence.

KW - acute pancreatitis

KW - clinical trials

KW - drugs

KW - medical therapy

KW - primary prevention

KW - resource utilization

KW - secondary prevention

UR - http://www.scopus.com/inward/record.url?scp=84931829731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931829731&partnerID=8YFLogxK

U2 - 10.1586/17474124.2015.1048225

DO - 10.1586/17474124.2015.1048225

M3 - Article

C2 - 25982517

AN - SCOPUS:84931829731

VL - 9

SP - 901

EP - 911

JO - Expert Review of Gastroenterology and Hepatology

JF - Expert Review of Gastroenterology and Hepatology

SN - 1747-4124

IS - 7

ER -